Meyka AI API is live for developers.Start building.
Advertisement
LifeMD, Inc.

LifeMD, Inc. (LFMD) Stock Overview

Explore LifeMD, Inc.’s financial performance, market position, analyst ratings, and future outlook.

LFMDNASDAQ
HealthcareMedical - Pharmaceuticals
$4.89
$0.02(0.41%)
U.S. Market opens in 54h 22m
Advertisement

LifeMD, Inc. (LFMD)

Meyka AI Score

Z

Key Financials

Market Cap236.5M
P/E Ratio-13.92
EPS (TTM)$-0.44
ROE-1.72%
Fundamental Analysis

AI Price Forecasts

1 Month$3.25
3 Months$7.11
1 Year Target$5.95

LFMD Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of LifeMD, Inc. (LFMD) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B+, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 58.92, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $5.95.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of -13.92 and a market capitalization of 236.5M. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
0.41%
5-Day Change
6.54%
1-Month Change
-4.68%
3-Month Change
63.00%
6-Month Change
39.71%
Year-to-Date (YTD) Change
43.40%
1-Year Change
-59.52%
3-Year Change
124.31%
5-Year Change
-62.79%
All-Time (Max) Change
2345.00%

Contact Information

866 351 5907
236 Fifth Avenue, New York City, NY, 10001

Company Facts

304 Employees
IPO DateJan 29, 2008
CountryUS
Actively Trading

Frequently Asked Questions